Elanco Animal Health Inc [ELAN] stock prices are up 4.76% to $22.25 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ELAN shares have gain 5.50% over the last week, with a monthly amount glided 2.20%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on November 21, 2025, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $27. Previously, Argus upgraded its rating to Buy on November 19, 2025, and kept the price target unchanged to $25. On October 07, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $24 on the stock. Leerink Partners upgraded its rating to an Outperform but stick to its price target of $18 on July 17, 2025. William Blair upgraded its rating to an Outperform. UBS started tracking with a Buy rating for this stock on December 09, 2024, and assigned it a price target of $18. In a note dated December 02, 2024, Leerink Partners initiated a Market Perform rating and provided a target price of $14 on this stock.
The stock price of Elanco Animal Health Inc [ELAN] has been fluctuating between $8.02 and $23.09 over the past year. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $22.25 at the most recent close of the market. An investor can expect a potential return of 7.87% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
The Elanco Animal Health Inc [NYSE:ELAN] reported sales of 4.59B for trailing twelve months, representing a surge of 10.39%. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.70 points at the first support level, and at 21.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.54, and for the 2nd resistance point, it is at 22.84.
Ratios To Look Out For
It’s worth pointing out that Elanco Animal Health Inc [NYSE:ELAN]’s Current Ratio is 2.40. Also, the Quick Ratio is 1.23, while the Cash Ratio stands at 0.35. Considering the valuation of this stock, the price to sales ratio is 2.41, the price to book ratio is 1.64 and price to earnings (TTM) ratio is 305.21.
Transactions by insiders
Recent insider trading involved Todd S and Jennifer G Young Li, Former CFO, that happened on Aug 11 ’25 when 49333.0 shares were purchased. Director, Kurzius Lawrence Erik completed a deal on Mar 07 ’25 to buy 10000.0 shares. Meanwhile, Director Kurzius Lawrence Erik bought 10000.0 shares on Mar 11 ’25.
